Photo of Dr Reena Khiroya

Dr Reena Khiroya

Telephone:

Email:

Location:

  • University College Hospital

GMC/GDC number:

7049742

Professional background

Dr Reena Khiroya is a consultant histo/cytopathologist specialising in lung and breast histopathology and diagnostic cytopathology.

Reena studied medicine at Imperial College London and completed her histopathology training in North Central Thames. After completion of her FRCPath examinations, she undertook subspecialist training at the Royal Brompton Hospital specialising in thoracic pathology.

Prior to taking up her consultant post, Reena also completed a clinical fellowship at UCLH specialising in lung and breast histopathology and diagnostic cytopathology.

Specialties

Research interests

Lung pathology, breast pathology

Publications

  • Khiroya R, Macaluso C, Montero MA, Wells AU, Chua F, Kokosi M, Maher TM, Devaraj A, Rice A, Renzoni EA, Nicholson AG. Pleuroparenchymal Fibroelastosis: A Review of Histopathologic Features and the Relationship Between Histologic Parameters and Survival. Am J Surg Pathol. 2017 Dec;41(12):1683-1689
  • Laggner U, Khiroya R, Wotherspoon AC, Desai S, Nicholson AG. MALT lymphoma arising on a background of reactive pulmonary lymphoid hyperplasia in a patient with Systemic Lupus Erythematosus. Histopathology. 2018 Mar;72(4):704-706
  • Perrotta F, Khiroya R, Russell P, Ekeowa U, Saleem A, Borg E, Ahmad T, Falzon M, Forster M, Navani N. Diagnosis of Combined Adenocarcinoma Small Cell Lung Cancer By Endobronchial Ultrasound Transbronchial Needle Aspiration. J Bronchology Interv Pulmonol. 2019 Apr;26(2):e20-e22
  • Montero MA, Osadolor T, Khiroya R, Salcedo MT, Robertus JL, Rice A, Nicholson AG, Roman A, Monforte V. Restrictive Allograft Syndrome And Idiopathic Pleuroparenchymal Fibroelastosis: Do They Really Have The Same Histology? Histopathology. 2017 Jun;70(7):1107-1113
  • Sinharay R, Mithra S, Patel P, Ah-Moye A, Morrow S, Khiroya R, Falzon M, Borg E, Ahmed T, Forster M, Navani N. EGFR mutation specific immunohistochemistry revolutionises time to treatment with tyrosine kinase inhibitors (TKIs). Lung Cancer. 2018. 115. 115:S24
  • Arce Vargas F, Furness AJS, Litchfield K, Joshi K, Rosenthal R, Ghorani E, Solomon I, Lesko MH, Ruef N, Roddie C, Henry JY, Spain L, Ben Aissa A, Georgiou A, Wong YNS, Smith M, Strauss D, Hayes A, Nicol D, O'Brien T, Mårtensson L, Ljungars A, Teige I, Frendéus B; TRACERx Melanoma; TRACERx Renal; TRACERx Lung consortia, Pule M, Marafioti T, Gore M, Larkin J, Turajlic S, Swanton C, Peggs KS, Quezada SA. Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies. Cancer Cell. 2018 Apr 9;33(4):649-663.
  • Patrini D, Scolamiero L, Khiroya R, Lawrence D, Borg E, Hayward M, Panagiotopoulos N.Mediastinal hemangioendothelioma: Case report and review of the literature. Respir Med Case Rep. 2017 Jun 3;22:19-23.
  • Stamatopoulos A, Patrini D, Mitsos S, Khiroya R, Borg E, Hayward M, Lawrence D, Panagiotopoulos N. An unusual late onset of pulmonary alveolar microlithiasis: A case report and literature review. Respir Med Case Rep. 2017 May 31;22:24-27.
  • Stamatopoulos A, Patrini D, Koletsis E, Borg E, Khiroya R, Hayward M, Lawrence D, Panagiotopoulos N. IgG4 related lung disease extending to the thoracic vertebrae. Respir Med Case Rep. 2016 Oct 7;19:162-165.